glycyrrhizin
acid
fig
also
known
glycyrrhizin
triterpenoid
saponin
obtain
root
rhizom
extract
liquoric
licoric
us
english
glycyrrhiza
glabra
normal
dri
licoric
root
extract
may
contain
around
saponin
along
compound
polyphenol
saponin
triterpen
etc
one
triterpen
found
extract
triterpen
aglycon
glycyrrhetin
acid
enoxolon
purif
use
sever
extract
techniqu
give
usual
monoammonium
glycyrrhetin
salt
purifi
product
world
health
organ
report
glycyrrhizin
recommend
compound
must
name
glycyrrhizin
acid
accord
report
glycyrrhizin
name
given
correctli
licoric
extract
saponin
glycyrrhizin
glycyrrhizin
acid
use
synonym
although
common
practic
literatur
chapter
follow
recommend
use
second
term
saponin
name
saponin
carboxyl
acid
monoammonium
salt
commonli
employ
sweeten
report
time
sweeter
sucros
saponin
also
wide
employ
sever
tradit
chines
tibetan
indian
medicin
prepar
stronger
neominophagen
c
glycyrrhetin
acidcontain
iv
prepar
employ
treatment
chronic
hepat
diseas
market
japan
china
korea
taiwan
indonesia
india
mongolia
intent
chapter
report
wide
rang
pharmacolog
activ
report
literatur
saponin
aglycon
inclus
aglycon
chapter
justifi
due
fact
saponin
oral
bioavail
absorb
glycyrrhetin
acid
hydrolysi
carbohydr
moieti
intestin
bacteria
sinc
sever
report
publish
regard
compound
ca
time
period
cover
chapter
onward
use
scifind
scientif
literatur
search
servic
sever
articl
mention
glycyrrhizin
glycyrrhetin
acid
titl
andor
abstract
found
fig
mention
earlier
use
glycyrrhizin
acid
search
term
give
reduc
number
articl
respons
due
enorm
number
public
select
period
decid
focu
chapter
public
report
pharmacolog
activ
saponin
aglycon
close
relat
compound
sever
japanes
korean
mostli
chines
patent
found
bibliograph
research
mention
relat
use
sweetenerflavor
agent
herbaldrug
prepar
therefor
left
review
sever
find
report
last
year
regard
anticanc
properti
glycyrrhizin
acid
wang
et
al
report
vitro
activ
gastric
cancer
cell
line
saponin
abl
prevent
cell
prolifer
adhes
migrat
dose
observ
also
express
survivin
significantli
decreas
order
evalu
carbohydr
moieti
import
anticanc
properti
yang
et
al
synthes
two
monoglucuronid
mean
glucuronidas
aspergillu
sp
scheme
author
report
obtain
effect
hela
cancer
cell
line
valu
respect
acid
monoglucuronid
also
best
epiderm
growth
factor
receptor
egfr
inhibitor
molecular
dock
simul
indic
also
abl
bind
egfr
suggest
anticanc
properti
glucuronid
relat
egfr
inhibit
huang
et
al
order
clarifi
mechan
anticanc
activ
lung
adenocarcinoma
cell
line
evalu
express
sever
enzym
vitro
model
found
anticanc
activ
cancer
cell
line
accord
author
relat
inhibit
thromboxan
synthas
result
also
found
vivo
mous
model
use
western
blot
assay
inhibit
highmobl
group
box
protein
act
outsid
cellular
milieu
proinflammatori
cytokin
also
relat
anticanc
properti
smolarczyk
et
al
report
employ
vivo
tumor
model
use
inhibit
cell
growth
prolifer
mice
author
conclud
cell
growth
inhibit
probabl
due
inhibit
extracellular
media
wang
et
al
determin
abl
attenu
level
tumor
necrosi
interleukin
activ
nuclear
factorkb
signal
pathway
hippocampu
neonat
rat
exposur
isofluran
gener
anesthet
drug
moreov
treatment
also
prevent
deficit
spatial
memori
relat
isofluran
use
pancreat
trauma
model
male
wistar
rat
xiang
et
al
report
treatment
min
induc
trauma
led
lower
serum
level
compar
control
group
treatment
saponin
also
increas
sevenday
surviv
rate
anim
subject
experiment
model
zhang
et
al
report
neuroprotect
effect
postischem
brain
mice
pathway
glycyrrhizin
acid
licoric
flavonoid
test
vitro
separ
group
found
zhao
et
al
modul
secret
sever
cytokin
macrophag
raw
cell
induc
lipopolysaccharid
lp
fu
et
al
report
present
antiinflammatori
activ
lpsstimul
raw
cell
disrupt
lipid
raft
inhibit
tolllik
transloc
raft
wang
et
al
report
abl
reduc
xylen
carrageenan
acet
acidinduc
rat
paw
edema
nocicept
induc
formalin
acet
acid
effect
hot
plate
test
author
also
observ
downregul
level
induc
nitric
oxid
synthas
ino
investig
effect
subarachnoid
hemorrhag
sah
rat
model
chang
et
al
report
saponin
exert
antiinflammatori
effect
reduc
sahinduc
vasospasm
mostli
attenu
peroxisom
proliferatoractiv
receptor
gamma
research
group
report
sah
model
treatment
also
abl
attenu
ultrashort
time
express
tolllik
receptor
tlr
saponin
also
subject
clinic
trial
regard
antiinflammatori
activ
xiao
et
al
conduct
random
trial
children
present
henochschonlein
purpura
hsp
order
verifi
function
regulatori
tcell
treg
cell
peripher
blood
patient
group
treat
significantli
differ
serum
level
treatment
differ
transform
growth
factorbeta
serum
level
treatment
author
conclud
abl
reduc
function
without
notic
effect
treg
function
glycyrrhizin
acid
also
trial
patient
chronic
urticaria
eighti
four
patient
diseas
random
two
group
one
mg
oral
tablet
three
time
per
day
levocetirizin
antiallerg
drug
compound
administ
fourweek
period
author
conclud
superior
levocetirizin
could
use
treat
chronic
urticaria
worth
notic
oral
bioavail
hydrolyz
form
glycyrrhetin
acid
absorb
therefor
observ
pharmacolog
activ
probabl
due
known
antiinflammatori
activ
see
sect
chapter
rather
magnesium
isoglycyrrhizin
magnesium
salt
acid
found
luo
et
al
effect
treatment
hepat
e
sever
jaundic
clinic
trial
patient
patient
receiv
intraven
inject
mg
magnesium
day
week
zhang
et
al
conduct
clinic
trial
patient
digest
tract
cancer
order
verifi
hepatoprotect
activ
standard
cancer
chemotherapi
author
observ
group
undergo
chemotherapi
treat
saponin
mg
iv
day
present
significantli
lower
liver
transaminas
level
increas
level
neutrophil
granulocyt
white
blood
cell
compar
control
group
standard
chemotherapi
also
investig
hepatoprotect
activ
hsiang
et
al
investig
gene
express
cell
treat
vitro
independ
silymarin
ursodeoxychol
acid
natur
product
also
known
hepatoprotect
properti
author
conclud
compound
inhibit
activ
dosedepend
manner
compound
regul
express
gene
relat
oxid
stress
apoptosi
cell
meng
et
al
conduct
metaanalysi
random
clinic
trial
regard
hepatoprotect
activ
patient
alcohol
liver
diseas
analysi
conclud
trial
level
alanin
aspart
aminotransferas
well
transpeptidas
lower
control
group
treatment
saponin
investig
patient
chronic
hepat
b
yin
et
al
found
threeweek
treatment
reduc
express
inflammatori
cytokin
antinuclear
antibodi
ana
treat
patient
compar
control
group
treat
chronic
hepat
b
either
magnesium
isoglicyrrhizin
compar
clinic
trial
report
cai
et
al
trial
involv
patient
divid
two
group
one
group
treat
intraven
magnesium
salt
saponin
also
iv
day
week
case
liver
function
improv
patient
author
found
statist
differ
treatment
ding
et
al
investig
effect
acid
rat
carbon
tetrachlorid
induc
liver
fibrosi
found
treatment
increas
activ
enzym
glutathion
peroxidas
superoxid
dismutas
reduc
lipid
peroxid
level
malonodialdehyd
hydroxynonen
liver
protect
damag
caus
aldehyd
wang
et
al
found
treatment
cell
caus
increas
mrna
protein
level
gene
encod
monooxygenas
respons
drug
metabol
steroid
biosynthesi
author
also
found
induct
mediat
activ
pregnan
x
receptor
pxr
result
induct
express
inhibit
hepatoprotect
effect
also
studi
use
normal
human
liver
cell
line
acetaminopheninduc
damag
accord
report
chen
et
al
liquirtin
isoliquirtigenin
two
polyphenol
also
found
liquoric
root
extract
effect
hepatoprotect
agent
acetaminopheninduc
damag
gwak
et
al
investig
role
hepatocyt
apoptosi
found
known
inhibitor
abl
prevent
apoptosi
cytochrom
c
releas
activ
huhbat
human
hepatocellular
carcinoma
transfect
bile
acid
transport
cell
line
glycyrrhizin
acid
known
literatur
antivir
agent
clinic
relev
virus
hiv
sarscoronaviru
duan
et
al
report
activ
porcin
reproductori
respiratori
syndrom
viru
prrsv
relev
veterinari
medicin
swine
industri
saponin
abl
inhibit
mainli
penetr
stage
viru
cycl
investig
known
anti
hiv
activ
saponin
li
et
al
found
among
compound
isol
liquoric
extract
high
bind
constant
conserv
core
sequenc
loop
region
region
accord
author
bind
glycophospholipid
occur
lead
viru
entri
host
cell
indic
saponin
antihiv
activ
inhibit
viru
entri
stage
use
hepat
c
viru
hcv
infect
cell
model
matsumoto
et
al
report
inhibit
releas
hcv
particl
suppress
viral
entri
reproduct
stage
observ
ashfaq
et
al
also
investig
antihcv
activ
saponin
report
treatment
hcvinfect
hepat
cell
led
suppress
hcv
core
gene
mrna
protein
level
coadministr
interferon
caus
synergist
effect
xiao
zhou
report
reduc
human
neutrophil
elastaseinduc
mucin
ac
overproduct
human
bronchial
epitheli
cell
cultur
interact
human
hemoglobin
hb
studi
sil
et
al
author
report
interact
saponin
protein
reduc
hbmediat
oxid
damag
without
affect
oxygen
bind
properti
hb
antithrombin
activ
alreadi
known
sinc
glycyrrhizin
acid
found
weak
vitro
vivo
thrombin
inhibitor
unlik
antithrombin
agent
saponin
act
alloster
inhibitor
glycyrrhetin
acid
howev
thrombin
inhibit
activ
indic
carbohydr
moieti
saponin
import
alloster
site
interact
result
mind
paula
et
al
synthes
deriv
aim
simplifi
carbohydr
scaffold
synthes
compound
hemiphtal
scheme
present
better
vitro
antithrombin
activ
thrombin
increas
thrombin
time
indic
carboxyl
acid
moieti
present
saponin
phthalat
import
recognit
alloster
site
investig
freerad
scaveng
abil
imai
et
al
report
glycyrrhetin
acid
abl
scaveng
dpph
radic
hydroxyl
superoxid
anion
radic
sever
report
regard
design
synthesi
pharmacolog
evalu
glycyrrhetin
acid
deriv
toward
compound
improv
anticanc
properti
sinc
chapter
focus
mainli
pharmacolog
properti
along
close
relat
deriv
report
regard
anticanc
activ
detail
reader
interest
indepth
articl
regard
chemic
modif
aglycon
structur
recommend
review
articl
czuk
well
review
articl
previous
mention
chapter
kim
et
al
report
present
vitro
cytotox
activ
human
lung
adenocarcinoma
cell
line
also
abl
reduc
vivo
tumor
induc
cell
cultur
inject
balbc
nunu
mice
employ
rm
cell
highli
metastat
rasmyctransform
serumfre
mous
embryo
yamaguchi
et
al
found
cytotox
effect
model
due
downregul
glutathion
disrupt
redox
balanc
cell
xu
et
al
use
human
myeloma
cell
line
report
induc
vitro
apoptosi
cell
line
downregul
survivin
gene
express
arrest
cell
phase
aim
studi
potenti
use
chemoprotect
agent
kowsalya
et
al
induc
buccal
pouch
carcinogenesi
hamster
use
anthracen
dmba
tumor
initi
oral
administr
mgkg
along
dmba
prevent
tumor
format
anim
model
charma
et
al
report
apoptot
effect
human
breast
cancer
cell
line
due
activ
modul
protein
kinas
bforkhead
box
transcript
factor
pathway
work
hepat
stellat
cell
hsc
cell
immunosuppress
capabl
relat
develop
hepatocellular
carcinoma
kuang
et
al
found
abl
reduc
vitro
hscmediat
immunosuppress
reduc
tcell
apoptosi
regulatori
treg
cell
express
turn
lead
increas
tcell
activ
hepatocellular
carcinoma
cell
xie
et
al
report
inhibit
epiderm
growth
factor
egf
induc
prolifer
hacat
cell
human
keratinocyt
cell
line
like
suppress
extracellular
signalregul
kinas
signal
pathway
vitro
studi
prostat
cancer
cell
line
lncap
conduct
li
et
al
indic
activ
cell
probabl
due
suppress
dehydrogenas
type
iii
mrna
express
via
activ
eukaryot
initi
factor
wang
et
al
investig
cytotox
effect
pituitari
adenoma
cancer
cell
line
mmq
author
report
triterpen
induc
apoptosi
cell
activ
mitochondriamedi
reactiv
oxygen
speci
ro
mitogenactiv
protein
kinas
mapk
pathway
huang
et
al
report
abl
suppress
prolifer
nonsmal
cell
lung
cancer
nsclc
line
cell
inhibit
thromboxan
synthas
activ
erkcreb
signal
investig
effect
metastat
cellinvad
abil
sever
cancer
cell
line
jayasooriya
et
al
found
capabl
downregul
matrix
vascular
endotheli
growth
factor
vegf
via
inhibit
phosphatidylinositol
kinas
aktdepend
activ
report
glycyrrhizin
acid
also
present
hepatoprotect
activ
mahmoud
et
al
observ
abl
counteract
cyclophosphamideinduc
hepatotox
rat
via
activ
nuclear
factorerythroid
relat
factor
factor
also
involv
chemoprotect
mechan
carbon
tetrachlorideinduc
liver
fibrosi
mice
chen
et
al
report
triterpen
abl
upregul
increas
activ
antioxid
enzym
liver
glycyrrhetin
acid
also
chemoprotect
agent
hepatotox
wistar
rat
via
attenu
oxid
stress
inflamm
hyperprolifer
accord
hasan
et
al
investig
antileishmani
activ
experiment
viscer
leishmaniasi
model
gupta
et
al
report
activ
occur
nitric
oxid
upregul
proinflammatori
cytokin
express
activ
kinas
research
group
later
report
activ
also
depend
phosphatasedepend
modul
cellular
map
kinas
kalani
et
al
effort
find
new
afford
antimalari
agent
report
vitro
anti
activ
vivo
activ
cours
treatment
research
group
found
also
antifilari
agent
activ
vitro
microfilaria
adult
worm
amid
synthes
group
abl
affect
microfilaria
adult
worm
long
et
al
report
activ
methicilinresist
staphylococcu
aureu
mrsa
major
sourc
complic
infect
hospit
environ
accord
author
present
vitro
bactericid
activ
subleth
concentr
abl
reduc
express
gene
relat
aureu
virul
saer
hla
investig
effect
acid
fig
periodont
pathogen
porphyromona
gingivali
kim
et
al
report
reduc
bacteri
lpsinduc
permeabl
suppress
repress
endotheli
product
glycyrrhetin
acid
also
known
antiinflammatori
activ
act
dehydrogenas
inhibitor
enzym
respons
convers
cortisol
fig
cortison
result
indirect
glucocorticoid
antiinflammatori
agent
extend
cortisol
halflif
carbenexolon
hemisuccin
ester
use
antiinflammatori
drug
unit
kingdom
chemic
structur
shown
fig
sinc
sever
report
regard
design
synthesi
pharmacolog
evalu
glycyrrhetin
acid
deriv
toward
new
antiinflammatori
agent
improv
properti
regard
natur
product
decid
order
extend
review
size
focu
new
report
antiinflammatori
activ
puchner
et
al
test
efficaci
model
rheumatoid
arthriti
htnftg
mice
found
triterpen
effect
model
compar
posit
control
tnf
inhibitor
investig
antiinflammatori
activ
cell
chen
et
al
report
suppress
tnfinduc
inflamm
cell
cultur
diminish
activ
wang
et
al
report
use
macrophag
induc
lp
alter
cell
viabil
suppress
activ
inhibit
express
sever
proinflammatori
gene
attenu
product
prostaglandin
reactiv
oxygen
speci
ro
studi
proinflammatori
cytokin
effect
kao
et
al
report
compound
capabl
suppress
cytokin
product
differ
mechan
work
via
pathway
act
dissoci
glucocorticoid
receptor
gr
complex
zhang
et
al
report
competit
glyoxalas
inhibitor
k
author
also
studi
crystal
structur
complex
glyoxalas
iglycyrrhetin
acid
indic
carboxyl
acid
moieti
triterpen
import
interact
inspir
previou
report
regard
chemoprotect
effect
wu
et
al
report
act
chemoprotect
agent
cisplatininduc
nephrotox
balbc
mice
effect
accord
author
relat
upregul
downregul
kong
et
al
report
act
skin
protector
uvinduc
photoag
mous
model
author
also
found
protect
effect
probabl
due
antiinflammatori
antioxid
properti
moon
et
al
investig
effect
vitro
model
adipogenesi
found
triterpen
alter
fat
mass
affect
adipogenesi
matur
preadipocyt
lipolysi
matur
adipocyt
also
investig
antiobes
properti
liquoric
park
et
al
report
suppress
activ
cannabinoid
type
receptor
induc
endogen
agonist
anandamid
research
effect
hemostasi
jiang
et
al
found
glycyrrhetin
acid
factor
xa
fxa
inhibitor
vitro
author
also
test
vivo
effect
rat
use
two
protocol
tail
bleed
venou
stasi
model
report
increas
prothrombin
time
reduc
thrombu
weight
mgkg
dose
compar
control
group
hardi
et
al
report
abl
inhibit
rotaviru
replic
vitro
assay
ineffect
assay
author
also
report
antivir
activ
occur
entri
stage
viral
cycl
great
rang
pharmacolog
biolog
activ
report
literatur
last
year
rang
explor
known
activ
signal
pathway
respons
anticanc
antiinflammatori
activ
scope
broaden
investig
antibacteri
antivir
properti
new
unreport
speci
viru
bacteria
also
new
unreport
activ
antiparasit
activ
glyoxalas
factor
xa
etc
sever
clinic
trial
regard
antiinflammatori
hepatoprotect
activ
also
discuss
wide
rang
report
activ
lead
import
question
safe
use
sweeten
glycyrrhizin
acid
current
consid
gener
recogn
safe
us
food
drug
administr
guidelin
maximum
permit
level
saponin
sever
prepar
also
european
commiss
report
glycyrrhizin
state
saponin
safe
consumpt
warn
maximum
daili
dose
higher
mg
glucocorticoid
effect
glycyrrhetin
acid
given
saponin
absorb
intestin
aglycon
hydrolysi
carbohydr
moieti
regard
report
properti
product
publish
articl
explor
chapter
describ
vitro
experiment
vivo
activ
mani
level
consid
high
use
drug
unless
high
dose
administ
way
quantiti
permit
regulatori
board
european
union
usa
activ
regard
potenti
one
use
prototyp
design
synthesi
new
improv
compound
structur
relat
andor
glycyrrhizin
acid
describ
eventu
sweeten
along
glycyrrhetin
acid
consid
scaffold
molecul
design
develop
new
bioactiv
compound
